Business
Propanc Biopharma Implements Reverse Stock Split to Meet Nasdaq Standards
The biopharmaceutical company aims to restore compliance with Nasdaq's minimum bid price requirement ahead of planned clinical studies.
Cancer Research
1 story about this topic.